» Articles » PMID: 9548449

Oral Administration of a Kampo (Japanese Herbal) Medicine Juzen-taiho-to Inhibits Liver Metastasis of Colon 26-L5 Carcinoma Cells

Overview
Specialty Oncology
Date 1998 Apr 21
PMID 9548449
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

We have investigated the inhibitory effect of oral administration of Juzen-taiho-to, a Kampo Japanese herbal medicine, on liver metastasis by the inoculation of a liver-metastatic variant (L5) of murine colon 26 carcinoma cells into the portal vein. Oral administration of Juzen-taiho-to for 7 days before tumor inoculation resulted in dose-dependent inhibition of liver tumor colonies and significant enhancement of survival rate as compared with the untreated control, without side effects. We also found that liver metastasis of L5 cells was enhanced in BALB/c mice pretreated with anti-asialo GM1 serum or 2-chloroadenosine, and in BALB/c nu/nu mice, compared to normal mice. This indicates that NK cells, macrophages, and T-cells play important roles in the prevention of metastasis of tumor cells. Juzen-taiho-to significantly inhibited the experimental liver metastasis of colon 26-L5 cells in mice pretreated with anti-asialo GM1 serum and untreated normal mice, whereas it did not inhibit metastasis in 2-chloroadenosine-pretreated mice or T-cell-deficient nude mice. Oral administration of Juzen-taiho-to activated peritoneal exudate macrophages (PEM) to become cytostatic against the tumor cells. These results show that oral administration of Juzen-taiho-to inhibited liver metastasis of colon 26-L5 cells, possibly through a mechanism mediated by the activation of macrophages and/or T-cells in the host immune system. Thus, Juzen-taiho-to may be efficacious for the prevention of cancer metastasis.

Citing Articles

Prolonged survival by combination treatment with a standardized herbal extract from Japanese Kampo-medicine (Juzentaihoto) and gemcitabine in an orthotopic transplantation pancreatic cancer model.

Napp J, Siebel P, Rausch H, Kuchta K, Efferth T, Alves F Front Oncol. 2024; 14:1454291.

PMID: 39723364 PMC: 11669038. DOI: 10.3389/fonc.2024.1454291.


Generation and Accumulation of Various Advanced Glycation End-Products in Cardiomyocytes May Induce Cardiovascular Disease.

Takata T, Inoue S, Masauji T, Miyazawa K, Motoo Y Int J Mol Sci. 2024; 25(13).

PMID: 39000424 PMC: 11242264. DOI: 10.3390/ijms25137319.


Deciphering the Mechanism of Siwu Decoction Inhibiting Liver Metastasis by Integrating Network Pharmacology and In Vivo Experimental Validation.

Chu X, Xie F, Hou C, Zhang X, Wang S, Xie H Integr Cancer Ther. 2024; 23:15347354241236205.

PMID: 38462929 PMC: 10929042. DOI: 10.1177/15347354241236205.


Analysis of Crude, Diverse, and Multiple Advanced Glycation End-Product Patterns May Be Important and Beneficial.

Takata T, Masauji T, Motoo Y Metabolites. 2024; 14(1).

PMID: 38276293 PMC: 10819149. DOI: 10.3390/metabo14010003.


Potential of the Novel Slot Blot Method with a PVDF Membrane for Protein Identification and Quantification in Kampo Medicines.

Takata T, Masauji T, Motoo Y Membranes (Basel). 2023; 13(12).

PMID: 38132900 PMC: 10745123. DOI: 10.3390/membranes13120896.


References
1.
Fidler I . Selection of successive tumour lines for metastasis. Nat New Biol. 1973; 242(118):148-9. DOI: 10.1038/newbio242148a0. View

2.
Hamada M, Fujii Y, Yamamoto H, Miyazawa Y, Shui S, Tung Y . Effect of a kanpo medicine, zyuzentaihotô, on the immune reactivity of tumor-bearing mice. J Ethnopharmacol. 1988; 24(2-3):311-20. DOI: 10.1016/0378-8741(88)90160-2. View

3.
Haranaka K, Satomi N, Sakurai A, Haranaka R, Okada N, Kobayashi M . Antitumor activities and tumor necrosis factor producibility of traditional Chinese medicines and crude drugs. Cancer Immunol Immunother. 1985; 20(1):1-5. PMC: 11038218. DOI: 10.1007/BF00199765. View

4.
Saito T, Yamaguchi J . 2-Chloroadenosine: a selective lethal effect to mouse macrophages and its mechanism. J Immunol. 1985; 134(3):1815-22. View

5.
Ohnishi Y, Yasumizu R, Fan H, Liu J, Komatsu Y, Hosoya E . Effects of juzen-taiho-toh (TJ-48), a traditional Oriental medicine, on hematopoietic recovery from radiation injury in mice. Exp Hematol. 1990; 18(1):18-22. View